On Invalid Date, Xenetic Biosciences (NASDAQ: XBIO) reported Q3 2022 earnings per share (EPS) of -$0.06, up 53.85% year over year. Total Xenetic Biosciences earnings for the quarter were -$804.02 thousand. In the same quarter last year, Xenetic Biosciences's earnings per share (EPS) was -$0.13.
As of Q1 2023, Xenetic Biosciences's earnings has grown year over year. Xenetic Biosciences's earnings in the past year totalled -$6.91 million.
What is XBIO's earnings date?
Xenetic Biosciences's earnings date is Invalid Date. Add XBIO to your watchlist to be reminded of XBIO's next earnings announcement.
What was XBIO's revenue last quarter?
On Invalid Date, Xenetic Biosciences (NASDAQ: XBIO) reported Q3 2022 revenue of $414.25 thousand up 18.6% year over year. In the same quarter last year, Xenetic Biosciences's revenue was $349.27 thousand.
What was XBIO's revenue growth in the past year?
As of Q1 2023, Xenetic Biosciences's revenue has grown 58.52% year over year. This is 2.84 percentage points lower than the US Biotechnology industry revenue growth rate of 61.36%. Xenetic Biosciences's revenue in the past year totalled $1.55 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.